Shandra Eisenga Human Cell and Tissue Product Safety Act

12/18/2024, 11:56 AM

Shandra Eisenga Human Cell and Tissue Product Safety Act

This bill requires the Department of Health and Human Services (HHS) to educate the public and health care providers about the benefits and risks of transplants that use human cell or tissue products, including the risk of infections.

HHS must develop the educational campaign after taking into consideration information about products that carry the highest risk of transmitting infections to transplant recipients. HHS may award grants to other entities to conduct public awareness initiatives and media campaigns about the risk of infections. 

The bill also establishes specific civil penalties for violations of laws regarding the spread of communicable diseases and regulations regarding procedures for human cell or tissue products.

Bill 118 hr 7188, also known as the Shandra Eisenga Human Cell and Tissue Product Safety Act, is a piece of legislation introduced in the US Congress. The purpose of this bill is to enhance the safety and oversight of human cell and tissue products used in medical procedures.

The bill is named after Shandra Eisenga, a patient who suffered serious health complications after receiving a contaminated human cell and tissue product during a medical procedure. The goal of the legislation is to prevent similar incidents from occurring in the future by implementing stricter regulations and oversight measures.

Some key provisions of the Shandra Eisenga Human Cell and Tissue Product Safety Act include: 1. Establishing a national registry for human cell and tissue products, which will track the distribution and use of these products to ensure they meet safety standards. 2. Requiring manufacturers of human cell and tissue products to adhere to strict quality control measures and report any adverse events or safety concerns. 3. Increasing penalties for violations of safety regulations related to human cell and tissue products. 4. Providing funding for research and development of new technologies to improve the safety and efficacy of these products. Overall, the Shandra Eisenga Human Cell and Tissue Product Safety Act aims to protect patients from the risks associated with contaminated or unsafe human cell and tissue products. By implementing stricter regulations and oversight measures, the bill seeks to improve the safety and quality of these products used in medical procedures across the United States.
Congress
118
Number
HR - 7188
Introduced on
2024-02-01
# Amendments
0
Sponsors
+5
Cosponsors
+5

Variations and Revisions

11/22/2024
Text
PDF
XML

Status of Legislation

Bill Introduced
Introduced to House
Passed in House
Introduced to Senate
Senate to Vote

Purpose and Summary

Shandra Eisenga Human Cell and Tissue Product Safety Act

This bill requires the Department of Health and Human Services (HHS) to educate the public and health care providers about the benefits and risks of transplants that use human cell or tissue products, including the risk of infections.

HHS must develop the educational campaign after taking into consideration information about products that carry the highest risk of transmitting infections to transplant recipients. HHS may award grants to other entities to conduct public awareness initiatives and media campaigns about the risk of infections. 

The bill also establishes specific civil penalties for violations of laws regarding the spread of communicable diseases and regulations regarding procedures for human cell or tissue products.

Bill 118 hr 7188, also known as the Shandra Eisenga Human Cell and Tissue Product Safety Act, is a piece of legislation introduced in the US Congress. The purpose of this bill is to enhance the safety and oversight of human cell and tissue products used in medical procedures.

The bill is named after Shandra Eisenga, a patient who suffered serious health complications after receiving a contaminated human cell and tissue product during a medical procedure. The goal of the legislation is to prevent similar incidents from occurring in the future by implementing stricter regulations and oversight measures.

Some key provisions of the Shandra Eisenga Human Cell and Tissue Product Safety Act include: 1. Establishing a national registry for human cell and tissue products, which will track the distribution and use of these products to ensure they meet safety standards. 2. Requiring manufacturers of human cell and tissue products to adhere to strict quality control measures and report any adverse events or safety concerns. 3. Increasing penalties for violations of safety regulations related to human cell and tissue products. 4. Providing funding for research and development of new technologies to improve the safety and efficacy of these products. Overall, the Shandra Eisenga Human Cell and Tissue Product Safety Act aims to protect patients from the risks associated with contaminated or unsafe human cell and tissue products. By implementing stricter regulations and oversight measures, the bill seeks to improve the safety and quality of these products used in medical procedures across the United States.
Alternative Names
Official Title as IntroducedTo require the Secretary of Health and Human Services to conduct a national, evidence-based education campaign to increase public and health care provider awareness regarding the potential risks and benefits of human cell and tissue products transplants, and for other purposes.
Policy Areas
Health
Potential Impact
Administrative law and regulatory procedures•
Civil actions and liability•
Congressional oversight•
Department of Health and Human Services•
Health programs administration and funding•
Health promotion and preventive care•
Organ and tissue donation and transplantation

Comments

APPROVED
CP
Cairo Parsons
@lemon_balm_glenlivet_cress74309
I don't like this new bill, it's gonna mess things up for me.
APPROVED
PB
Persephone Beatty
@nutmeg_bunium_persicum_cubeb05753
I don't like this new bill at all. It's gonna mess things up for a lot of us. Just doesn't sit right with me. We need to pay attention to what's really going on here.

Related

Committee:  Energy and Commerce
Bill Update Alert:  Shandra Eisenga Human Cell and Tissue Product Safety Act

Recent Activity

Latest Summary12/11/2024

Shandra Eisenga Human Cell and Tissue Product Safety Act

This bill requires the Department of Health and Human Services (HHS) to educate the public and health care providers about the benefits and risks of transplants that u...

Latest Action12/17/2024
Received in the Senate.